Twist Bioscience (TWST) Depreciation and Depletion (2022 - 2026)

Twist Bioscience has disclosed Depreciation and Depletion across 5 years of filings, most recently posting $6.1 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $23.5 million (down 8.2% YoY), while the FY2025 annual figure was $23.8 million, down 12.82% from the prior year.
• Depreciation and Depletion climbed to $6.1 million in Q1 2026, from $5.9 million in the prior quarter.
• Over the last five years, Depreciation and Depletion for TWST reached as high as $7.3 million in Q3 2023 and fell as low as $3.9 million in Q4 2022.
• The 5-year median for Depreciation and Depletion is $6.1 million (2024), against an average of $6.2 million.
• Annual changes were most pronounced in 2023 — Depreciation and Depletion jumped 76.92% — and 2025, when it dropped 17.14%.
• A 5-year view of Depreciation and Depletion shows it stood at $3.9 million in 2022, then surged by 76.92% to $6.9 million in 2023, then fell by 11.59% to $6.1 million in 2024, then decreased by 3.28% to $5.9 million in 2025, then increased by 3.39% to $6.1 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $6.1 million, $5.9 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.